Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,212) with videos related to
Page
of 122
Sort By:
JAMA
|
January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
J H Alexander, R A Sparapani, K W Mahaffey, et al.
American Heart Journal
|
February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial
Thomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
Cardiovascular Drugs and Therapy
|
May 19, 2017
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect
Patrícia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal
|
December 24, 2018
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Karen P Alexander, Marc A Brouwer, Hillary Mulder, et al.
American Heart Journal
|
December 16, 2014
Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial
Masaya Koshizaka, Renato D Lopes, Eric M Reyes, et al.
The British Journal of Dermatology
|
November 3, 2019
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
H Alexander, A S Paller, C Traidl-Hoffmann, et al.
Circulation
|
November 15, 2013
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Ziad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
Journal of Thrombosis and Thrombolysis
|
April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin
Patricia O Guimarães, Renato D Lopes, John H Alexander, et al.
European Heart Journal
|
May 30, 2025
Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial
William A E Parker, Thomas A Nelson, Justin Lee, et al.
Page
of 122
Search research articles
Search
Showing results (991-1000 of 1,212) with videos related to
Sort By:
Page
of 122
JAMA
|
January 27, 2000
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
J H Alexander, R A Sparapani, K W Mahaffey, et al.
American Heart Journal
|
February 15, 2011
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial
Thomas J Povsic, Mauricio G Cohen, Roxana Mehran, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
Cardiovascular Drugs and Therapy
|
May 19, 2017
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect
Patrícia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal
|
December 24, 2018
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Karen P Alexander, Marc A Brouwer, Hillary Mulder, et al.
American Heart Journal
|
December 16, 2014
Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial
Masaya Koshizaka, Renato D Lopes, Eric M Reyes, et al.
The British Journal of Dermatology
|
November 3, 2019
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
H Alexander, A S Paller, C Traidl-Hoffmann, et al.
Circulation
|
November 15, 2013
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Ziad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.
Journal of Thrombosis and Thrombolysis
|
April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin
Patricia O Guimarães, Renato D Lopes, John H Alexander, et al.
European Heart Journal
|
May 30, 2025
Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial
William A E Parker, Thomas A Nelson, Justin Lee, et al.
Page
of 122